Privi Speciality Chemicals Sees Mixed Week: -0.84% Price, Outperforms Sensex Slightly

Feb 14 2026 02:07 PM IST
share
Share Via
Privi Speciality Chemicals Ltd closed the week ending 13 February 2026 at Rs.2,737.30, down 0.84% from the previous Friday’s close of Rs.2,760.60. This modest decline came amid a mixed market backdrop, with the Sensex falling 0.54% over the same period. The week was marked by the company’s robust quarterly results announced on 10 February, which highlighted strong revenue and profit growth, yet the stock price showed limited positive reaction, reflecting investor caution amid valuation concerns and liquidity considerations.

Key Events This Week

9 Feb: Stock opens at Rs.2,745.35, down 0.55% as Sensex gains 1.04%

10 Feb: Quarterly results released showing 25.37% revenue growth and 92.93% PAT surge

12 Feb: Stock rallies 1.86% to Rs.2,800.10 despite Sensex decline

13 Feb: Stock closes week at Rs.2,737.30, down 2.24% on heavy market sell-off

Week Open
Rs.2,745.35
Week Close
Rs.2,737.30
-0.29%
Week High
Rs.2,800.10
vs Sensex
-0.30%

9 February 2026: Opening Week with Slight Decline Amid Broad Market Gains

Privi Speciality Chemicals Ltd began the week at Rs.2,745.35, registering a decline of 0.55% compared to the previous Friday’s close of Rs.2,760.60. This contrasted with the Sensex, which gained 1.04% to close at 37,113.23. The stock’s underperformance on this day suggested early investor caution ahead of the company’s quarterly results announcement scheduled for the following day.

10 February 2026: Strong Quarterly Results Announced, Stock Reaction Muted

On 10 February, Privi Speciality Chemicals Ltd reported its December 2025 quarter results, showcasing a robust financial performance. Net sales surged 25.37% year-on-year to ₹1,283.35 crores for the half-year, while profit after tax (PAT) nearly doubled with a 92.93% increase to ₹171.90 crores. The company also recorded an improved return on capital employed (ROCE) of 19.32% and a reduced debt-equity ratio of 0.86 times, signalling strong operational efficiency and prudent financial management.

Despite these positive fundamentals, the stock price closed almost flat at Rs.2,745.80, up a mere 0.02%, underperforming the Sensex’s 0.25% gain to 37,207.34. This muted market response may reflect investor concerns over the company’s declining cash reserves, which fell to ₹16.44 crores, the lowest in recent periods, potentially signalling liquidity pressures.

Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.

  • - Strong fundamental track record
  • - Consistent growth trajectory
  • - Reliable price strength

Count on This Pick →

11 February 2026: Steady Gains Amid Market Stability

The stock edged higher by 0.11% to close at Rs.2,748.95, supported by a stable market environment as the Sensex rose 0.13% to 37,256.72. Trading volumes remained moderate at 5,860 shares, indicating cautious investor participation. The incremental gain reflected a consolidation phase following the quarterly results announcement.

12 February 2026: Stock Surges 1.86% Despite Sensex Decline

On 12 February, Privi Speciality Chemicals Ltd bucked the broader market trend by rallying 1.86% to Rs.2,800.10, its highest close of the week. This came even as the Sensex declined 0.56% to 37,049.40 amid profit-taking in other sectors. The stock’s outperformance was likely driven by investor focus on the company’s strong operational metrics, including its highest-ever debtors turnover ratio of 5.45 times, signalling improved receivables management and cash flow efficiency.

Holding Privi Speciality Chemicals Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

13 February 2026: Market Sell-Off Weighs on Stock, Closing Week Lower

The final trading day saw Privi Speciality Chemicals Ltd retreat 2.24% to Rs.2,737.30, amid a sharp Sensex decline of 1.40% to 36,532.48. The stock’s drop was more pronounced than the benchmark index, reflecting broader market weakness and possible profit-booking after the midweek rally. Volume was relatively low at 5,108 shares, indicating subdued investor enthusiasm as the week closed.

Date Stock Price Day Change Sensex Day Change
2026-02-09 Rs.2,745.35 -0.55% 37,113.23 +1.04%
2026-02-10 Rs.2,745.80 +0.02% 37,207.34 +0.25%
2026-02-11 Rs.2,748.95 +0.11% 37,256.72 +0.13%
2026-02-12 Rs.2,800.10 +1.86% 37,049.40 -0.56%
2026-02-13 Rs.2,737.30 -2.24% 36,532.48 -1.40%

Key Takeaways from the Week

Positive Signals: The company’s quarterly results demonstrated strong revenue growth of 25.37% and an impressive PAT increase of 92.93%, underscoring effective cost control and margin expansion. The ROCE of 19.32% and improved debt-equity ratio of 0.86 times reflect disciplined capital management and operational efficiency. The highest-ever debtors turnover ratio of 5.45 times indicates enhanced receivables management, supporting cash flow stability.

Cautionary Signals: Despite strong fundamentals, the stock price declined 0.84% over the week, underperforming the Sensex’s 0.54% fall. The company’s cash and cash equivalents dropped to ₹16.44 crores, the lowest in recent periods, raising concerns about liquidity. The Mojo Grade downgrade from Buy to Hold and a moderated financial trend score from 27 to 16 suggest tempered momentum and a more cautious outlook among analysts. The premium valuation noted in recent commentary may also be limiting upside in the near term.

Conclusion

Privi Speciality Chemicals Ltd’s week was characterised by a strong fundamental performance offset by subdued market response and a modest stock price decline. The company’s robust revenue and profit growth, alongside improved operational metrics, reinforce its competitive position within the specialty chemicals sector. However, liquidity considerations and valuation concerns have tempered investor enthusiasm, resulting in underperformance relative to the Sensex.

Investors analysing Privi Speciality Chemicals should weigh the company’s solid earnings momentum and capital efficiency against emerging risks related to cash reserves and market volatility. The Hold rating and Mojo Score of 57.0 reflect a balanced view, recognising both strengths and cautionary factors. Overall, the stock remains a noteworthy player with a strong long-term track record, though near-term price action may remain volatile.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News